Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.7 |